Canada Markets closed

Cronos Group Inc. (CRON.TO)

Toronto - Toronto Delayed Price. Currency in CAD
Add to watchlist
7.52-0.26 (-3.34%)
At close: 4:00PM EDT

Cronos Group Inc.

720 King Street West
Suite 320
Toronto, ON M5V 2T3
Canada
416-504-0004
http://www.thecronosgroup.com

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees631

Key Executives

NameTitlePayExercisedYear Born
Mr. Michael Ryan GorensteinChairman, Pres & CEO333.57kN/A1987
Mr. Jerry Filomena BarbatoChief Financial Officer299.63kN/A1976
Ms. Xiuming ShumExec. VP of Legal and Regulatory Affairs & Corp. Sec.190.18kN/A1986
Mr. Shayne J. LaidlawDirector of Investor Relations & StrategyN/AN/AN/A
Mr. Eric KleinHead of MarketingN/AN/AN/A
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Cronos Group Inc. operates as a cannabinoid company in the United States and internationally. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through ecommerce, retail, and hospitality partner channels. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. Its brand portfolio includes PEACE NATURALS, a global wellness platform; adult-use brands comprise COVE and Spinach; and hemp-derived CBD brands consists of Lord Jones and PEACE+. Cronos Group Inc. is based in Toronto, Canada.

Corporate Governance

Cronos Group Inc.’s ISS Governance QualityScore as of December 8, 2019 is 7. The pillar scores are Audit: 10; Board: 5; Shareholder Rights: 5; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.